{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/ja/reddit/r/stocks/comments/nuf3aq/biogen_biib_drug_aduhelm_aducanumab_approved_by/","result":{"data":{"site":{"siteMetadata":{"title":"国外股市热门","author":"Buzzing.cc","description":"用中文浏览国外股票社区里的热门讨论","keywords":["buzzing","美股","股票","股市"],"siteUrl":"https://stocks.buzzing.cc","telegram":"@stocks_top","iconUrl":"https://stocks.buzzing.cc/avatar.png","defaultSocialImageUrl":null,"social":[{"name":"Reddit Stocks","url":"https://www.reddit.com/r/stocks","external":true},{"name":"Reddit Investing","url":"https://www.reddit.com/r/investing","external":true},{"name":"Charlie Bilello's twitter","url":"https://twitter.com/charliebilello","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null}],"disqus":null,"utterances":null,"localize":[{"title":"Buzzing on Stocks","description":"See popular discussions in foreign stock communities in your native language","keywords":["buzzing","stocks","U.S. stocks"],"locale":"en","social":{"name":null,"url":null,"external":null},"menuLinks":[{"name":"Weekly Selection","url":"/en/issues","external":null}]},{"title":"國外股市熱門","description":"用中文瀏覽國外股票社區裡的熱門討論","keywords":["buzzing","美股","股票","股市"],"locale":"zh-Hant","social":null,"menuLinks":[{"name":"每週精選","url":"/zh-Hant/issues","external":null}]},{"title":"米国株式市場人気の話し合います","description":"人気の米国株式市場の話し合いまを日本語で閲覧","keywords":["buzzing","米国株式市場"],"locale":"ja","social":null,"menuLinks":[]}]}},"blogPost":{"id":"RedditPost-84b0d638-e669-59e8-b229-f334446d8612","excerpt":"Biogen's Aduhelm has been approved by the FDA to treat Alzheimer's Disease.\nTrading of Biogen (BIIB) is still halted as of 11:18 AM (Eastern). EDIT: Trading\nscheduled to resume at 1:30 PM (ET).\n\nAduhelm targets amyloid plaque deposits, long thought to be associated with the\ncognitive decline of…","body":"<!-- SC_OFF --><div class=\"md\"><p>Biogen&#39;s Aduhelm has been approved by the FDA to treat Alzheimer&#39;s Disease.  <del>Trading of Biogen (BIIB) is still halted as of 11:18 AM (Eastern).</del>  EDIT: Trading scheduled to resume at 1:30 PM (ET).</p>\n\n<p>Aduhelm targets amyloid plaque deposits, long thought to be associated with the cognitive decline of Alzheimer&#39;s Disease.  There are still many hurdles with translating the drug to profits, as a followup study is pending.  Pricing concerns based on drug efficacy raised by the Institute for Clinical and Economic Review (ICER) may also lower the upper limit of profitability.  Insurers may be hesitant to cover Aduhelm without a clearer demonstration of efficacy.</p>\n\n<p><a href=\"https://www.streetinsider.com/Corporate+News/FDA+Announces+Approve+of+Biogens+%28BIIB%29+Treatment+for+Alzheimers+Disease/18527815.html\">https://www.streetinsider.com/Corporate+News/FDA+Announces+Approve+of+Biogens+%28BIIB%29+Treatment+for+Alzheimers+Disease/18527815.html</a></p>\n</div><!-- SC_ON -->","slug":"/reddit/r/stocks/comments/nuf3aq/biogen_biib_drug_aduhelm_aducanumab_approved_by/","title":"Biogen (BIIB) drug Aduhelm (Aducanumab) Approved by FDA for Alzheimer's Disease Treatment","tags":["stocks","reddit"],"date":"June 08, 2021","dateISO":"2021-06-08T05:27:43.000Z","datetime":"2021-06-08 05:27","image":null,"imageAlt":null,"socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"84b0d638-e669-59e8-b229-f334446d8612","provider":"Reddit","url":"https://www.reddit.com/r/stocks/comments/nuf3aq/biogen_biib_drug_aduhelm_aducanumab_approved_by/","originalUrl":"https://www.reddit.com/r/stocks/comments/nuf3aq/biogen_biib_drug_aduhelm_aducanumab_approved_by/","imageRemote":null,"video":null,"channel":"stocks","channelUrl":"https://www.reddit.com/r/stocks","author":"Popochu","authorUrl":"https://www.reddit.com/user/Popochu","authorImage":null,"authorImageRemote":null,"authorSlug":"Popochu","score":41,"views":null,"sharedCount":null,"likeCount":null,"sharedContent":null,"parent":{"localize":[{"title":"バイオジェン社（BIIB）の医薬品Aduhelm（Aducanumab）がアルツハイマー型認知症治療薬としてFDAから承認を取得","the_new_excerpt":"バイオジェン社のAduhelmがアルツハイマー病の治療薬としてFDAに承認されました。\nバイオジェン(BIIB)の取引は午前11時18分(東部)現在、まだ停止しています。EDIT：取引\nは午後1時30分（東部時間）に再開される予定です。\n\nAduhelmは、長年、認知機能の低下に関連すると考えられてきたアミロイドプラークの沈着を標的としています。\n認知機能の低下に関係していると考えられてきた...","locale":"ja"},{"title":"百健公司（BIIB）的药物Aduhelm（Aducanumab）被FDA批准用于阿尔茨海默病的治疗","the_new_excerpt":"百健公司的Aduhelm已被FDA批准用于治疗阿尔茨海默病。\n截至上午11点18分（东部时间），百健公司（BIIB）的交易仍在停止。编辑：交易\n定于下午1:30（东部时间）恢复。\n\nAduhelm的目标是淀粉样斑块沉积，长期以来被认为是与\n的认知能力下降有关。","locale":"zh"},{"title":"百健公司（BIIB）的藥物Aduhelm（Aducanumab）被FDA批准用於阿爾茨海默病的治療","the_new_excerpt":"百健公司的Aduhelm已被FDA批准用於治療阿爾茨海默病。\n截至上午11點18分（東部時間），百健公司（BIIB）的交易仍在停止。編輯：交易\n定於下午1:30（東部時間）恢復。\n\nAduhelm的目標是澱粉樣斑塊沉積，長期以來被認爲是與\n的認知能力下降有關。","locale":"zh-Hant"}]}},"previous":{"id":"RedditPost-2a079905-8d66-5321-8d88-d66dc4662c80","excerpt":"","slug":"/reddit/r/wallstreetbets/comments/nuqg8h/woke_up_feeling_myself_decided_to_yolo_my_230k/","title":"Woke up feeling myself - Decided to YOLO my 230k portfolio on BB and CLOV...","date":"June 08, 2021","__typename":"SocialMediaPost","provider":"Reddit","parent":{"localize":[{"title":"自分の気分で目覚めた - BBとCLOVで23万ドルのポートフォリオをYOLOすることにした...","the_new_excerpt":null,"locale":"ja"},{"title":"一觉醒来，感觉自己--决定在BB和CLOV上对我的23万投资组合进行YOLO...。","the_new_excerpt":null,"locale":"zh"},{"title":"一覺醒來，感覺自己--決定在BB和CLOV上對我的23萬投資組合進行YOLO...。","the_new_excerpt":null,"locale":"zh-Hant"}]}},"next":{"id":"RedditPost-a7873a8d-958c-5959-924a-5276e2290152","excerpt":"It seems the consensus that the S&P (specifically vanguard's VOO) is the most\nbasic way to diversify holdings while keeping strong returns. (when only looking\nat US market).\n\nLooking at the sector breakdown, you can hold more assets, thus being more\ndiverse, by owning the individual sectors that…","slug":"/reddit/r/investing/comments/num9kb/a_failed_attempt_at_beating_voo/","title":"A failed attempt at beating VOO","__typename":"SocialMediaPost","date":"June 08, 2021","provider":"Reddit","parent":{"localize":[{"title":"VOOに勝つための失敗作","the_new_excerpt":"S&P（具体的にはvanguardのVOO）が最も優れているというコンセンサスが得られているようです。\nS&P（特にバンガードのVOO）は、強いリターンを維持しながら保有資産を分散させる最も基本的な方法であるということで一致しています。(米国市場だけを見た場合\n米国市場のみを見た場合）。)\n\nセクターの内訳を見ると、個々のセクターを保有することで、より多くの資産を保有することができ、より多様性があります。\nセクターの内訳を見ると、より多くの資産を保有することができ、その結果、より多様性を持つことができます...","locale":"ja"},{"title":"击败VOO的失败尝试","the_new_excerpt":"似乎大家都认为标准普尔指数（特别是先锋的VOO）是最基本的投资方式。\n的基本方式，在保持强劲回报的同时分散持有的资产。(当只看\n美国市场）。)\n\n从行业分类来看，你可以持有更多的资产，从而更加\n通过拥有个别行业，你可以持有更多的资产，从而变得更加多样化...","locale":"zh"},{"title":"擊敗VOO的失敗嘗試","the_new_excerpt":"似乎大家都認爲標準普爾指數（特別是先鋒的VOO）是最基本的投資方式。\n的基本方式，在保持強勁回報的同時分散持有的資產。(當只看\n美國市場）。)\n\n從行業分類來看，你可以持有更多的資產，從而更加\n通過擁有個別行業，你可以持有更多的資產，從而變得更加多樣化...","locale":"zh-Hant"}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"RedditPost-84b0d638-e669-59e8-b229-f334446d8612","previousId":"RedditPost-2a079905-8d66-5321-8d88-d66dc4662c80","nextId":"RedditPost-a7873a8d-958c-5959-924a-5276e2290152","maxWidth":1024,"siteMetadata":null,"locale":"ja","hrefLang":"ja-JA","originalPath":"/reddit/r/stocks/comments/nuf3aq/biogen_biib_drug_aduhelm_aducanumab_approved_by/","dateFormat":"YYYY-MM-DD"}},"staticQueryHashes":["1239077767","2744905544","3280999885"]}